Ajanta Pharmaceuticals will be included in the NSE's Nifty Midcap 50 index, replacing Aditya Birla Nuvo from next month.
According to the changes announced by India Index Services and Products Ltd (IISL), a subsidiary of NSE Strategic Investment Corporation, Ajanta Pharmaceuticals will be excluded from Nifty Midcap 50 index with effect from October 19, this year.
In its place, Aditya Birla Nuvo, the holding company of Aditya Birla Group, would be included in the index.
Nifty Midcap 50 index consists of stocks with an average free float market capitalisation ranging from Rs 1,000 crore to Rs 5,000 crore at the time of selection.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
